Bio Impact Capital LLC Rocket Pharmaceuticals, Inc. Transaction History
Bio Impact Capital LLC
- $511 Million
- Q2 2025
A detailed history of Bio Impact Capital LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 3,903,081 shares of RCKT stock, worth $11.4 Million. This represents 1.87% of its overall portfolio holdings.
Number of Shares
3,903,081
Previous 1,618,265
141.19%
Holding current value
$11.4 Million
Previous $10.8 Million
11.41%
% of portfolio
1.87%
Previous 2.0%
Shares
4 transactions
Others Institutions Holding RCKT
# of Institutions
220Shares Held
98.3MCall Options Held
611KPut Options Held
487K-
Rtw Investments, LP New York, NY17.7MShares$51.5 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$24.3 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$17.8 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$14 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $220M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...